Basket

0371265 - ÚMG 2012 RIV GB eng J - Journal Article
Šímová, Jana - Polláková, Veronika - Indrová, Marie - Mikyšková, Romana - Bieblová, Jana - Štěpánek, Ivan - Bubeník, Jan - Reiniš, Milan
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.
British Journal of Cancer. Roč. 105, č. 10 (2011), s. 1533-1541. ISSN 0007-0920. E-ISSN 1532-1827
R&D Projects: GA ČR GA301/07/1410; GA ČR GAP301/10/2174; GA ČR GA301/09/1024
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : 5-azacytidine * MHC class I downregulation * tumour chemoimmunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.042, year: 2011
Permanent Link: http://hdl.handle.net/11104/0204817